Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com

BusinesswireDec 12 01:41

Here's Why Arbutus (ABUS) Surged in Q3

Yahoo FinanceDec 6 21:20

Whitefort Capital Sends Letter To Arbutus Biopharma Board Of Directors; Believes Now Is The Time For Arbutus To Pursue A License And Collaboration Agreement With A Strategic Partner And Explore All Options For HBV Portfolio

BenzingaDec 3 21:24

Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat

Arbutus BiopharmaNov 26 13:00

Walmart To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

BenzingaNov 20 20:45

Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $5

Futu NewsNov 20 10:32 · Ratings